AstraZeneca sells right to heart failure, blood pressure drugs for $400 million

  • 📰 Reuters
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

British drugmaker AstraZeneca Plc said on Friday it would sell commercial rights for two of its heart failure and blood pressure medicines to German pharmaceutical company Cheplapharm Arzneimittel GmbH for $400 million.

FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvicsaid on Friday it would sell commercial rights for two of its heart failure and blood pressure medicines to German pharmaceutical company Cheplapharm Arzneimittel GmbH for $400 million.

Atacand is a prescription drug approved to treat heart failure and hypertension, while Atacand Plus is used for hypertension.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

People should walk for blood pressure .Poor human being.

this is terrible news

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in LAW

Law Law Latest News, Law Law Headlines